Chemotherapy Pharm Flashcards

1
Q
class 1 agents
class 2 agents
class 3 agents
A

• Class 1: all cells killed
; ex: nonspecific alkylating agents, nitrogen mustard

• Class 2: cell cycle specific; plateaus
ex: vinblastine, methotrexate

•	Class 3 agents: non-cycle specific but slower rate of kill than class 1; 
example: daunorubicin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

survival curves are ____

what does that mean?

A

logarithmic

-a given dose kills a constant fraction of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MDR

A

multidrug resistance

over production of glycoproteins that pump drugs out of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

nitrogen mustards def and mechanism (4 are?)

A

Mech: DNA is alkylated –> causes misreading and strand breaks

MICC - melphalan, ifosfamide, chlorambucil, cyclophasphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

melphalan and chlorambucil

A

nitrogen mustards; phenylalanine derivatives

orally; 1.5-2 hr half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clyclophosphamide

A

nitrogen mustard –>activated to aldophosphamide by hepatic cyt p450 –> hydrolized to active phosphoramide mustard in target cells

-inactivated by aldehyde dehydrogenase 

reduced hepatotoxicity BUT -->
o	Toxicities (different than the others) – immunosuppression, pulmonary fibrosis, cystitis, water retention, alopecia, carcinogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ifosfamide

A

Cyclophosphamide derivative for testicular cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 chloroethyl nitrosureas

A

carmustine

lomustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

nitrosureas

A

carmustine and lomustine
Mech: Alkylation, DNA crosslinking, and carbamoylation of proteins
o lipid soluble –> disappear rapidly from plasma into lipids/CNS = long half-life

toxicities: delayed/severe hematopoietic depression;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

which nitrosurea can be implantable wafer for treatment of malignant glioma.

A

carmustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cisplatin

A

platinum coordinate; only the cis-dichloro form is active. Used for testicular/ovarian cancer, and head/neck cancers.
• Mechanism: alkylation by dissociation of Cl- ions leaving a + charged complex –> crosslinks are formed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3 platinum coordination complex drugs

A

cisplatin
oxaliplatin
carboplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which form of cisplatin is active?

inactive?

A

cis-dichloro is active

plasma bound drug is inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

oxaliplatin

A

cisplatin analogue used to treat colorectal cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

toxicity of platinum coordinator complexes

A

myelosuppression, nephrotoxicity, ototoxicity; nephrotoxicity can be attenuated by administration of the free radical scavenger amifostine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

carboplatin

A

platinum coordinator complex with less renal toxicity; dose is limited by leukopenia and thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

procarbazine

A
nonspecific alkylator (DNA, RNA, protein)
•	treat Hodgkin's lymphoma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

classes of alkylating agents

A

nitrosureas
platinum coordinators
nitrogen mustards
procarbazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

vinca alkaloids

A

Vincristine and vinblastine

potent plant-derived antitumor agents
• Mechanism: INHIBITS microtubule formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

vincristine - class? toxicity?

A

vinca alkaloid

neurotoxicity and stimulates ADH release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

vinblastine - class? toxicity?

A

vinca alkaloid

myelosuppression and mucositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

2 taxanes?

A

paclitaxel and docetaxel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

paclitaxel

A

taxane from yew tree Taxus; inhibits microtubule reorganization

24
Q

which taxane is natural? which is semisynthetic?

A

docetaxel is semisynthetic

paclitaxel is natural

25
ixabepilone
binds directly to β-tubulin and, in contrast to the vinca alkaloids, promotes polymerization/stabilizes microtubules, arresting cells in G2/M. o Used for treatment of taxane- and anthracycline-resistant breast cancer.
26
2 Epipodophylotoxins
Etoposide and teniposide
27
etoposide and teniposide
from mandrake plant podophyllotoxin • Uses: Hodgkin's lymphoma, diffuse histiocytic lymphoma and lung small cell carcinoma • Mechanism: Inhibit topoisomerase II 
 • Toxicities: leukopenia, thrombocytopenia
28
2 derivatives from the plant alkaloid camptothecin their mechanism?
irinotecan and topotecan inhibit topoisomerase 1
29
irinotecan
derivative of plant alkaloid camptothecin inhibits topoisomerase 1 treatment of metastatic colorectal cancer.
30
topotecan
derivative of the plant alkaloid camptothecin inhibits topoisomerase 1 Effective for treatment of ovarian and small cell lung carcinoma.
31
2 anthracyclines
Daunorubicin and doxorubicin
32
Daunorubicin and doxorubicin
anthracyclines o Free radical and strand breaks formation o Inhibition of DNA topoisomerase II • CARDIOTOXICITY
33
dexrazoxane
a protectant, iron chelator that inhibits free radical formation can reduce cardiac damage from anthracyclines
34
what drug do you pair with anthracyclines (daunorubicin and doxorubicin) to prevent ROS and reduce cardiac damage?
dexrazoxane
35
bleomycin
antibiotic • causes depurination and depyrimidation--> strand breaks • NOT a substrate for MDR • Toxicity: sub-acute or chronic pneumonitis, lesions of the skin
36
what is NOT a substrate for MDR?
bleomycin
37
an anti-metabolite? | its antidote if there is toxicity?
methotrexate | leucovorin
38
methotrexate
- folic acid analogue; inhibits dihydrofolate reductase | 
39
folic acid analogue that is a competitive inhibitor of the enzyme dihydrofolate reductase?
methotrexate
40
leucovorin
treats MTX toxicity | by supplying reduced folate to cells
41
pyrimidine analogues
analogues of uridine or cytidine --> synthesis of defective DNA and chain termination 5GACC --> 5 fluorouracil, gemcitabine, azacitidine, capecitabine, cytosine arabinoside
42
5GACC
the pyrimidine analogues --> synthesis of defective DNA and chain termination 5 fluorouracil, gemcitabine, azacitidine, capecitabine, cytosine arabinoside
43
capecitabine
a 5-FU prodrug whose final step of activation is catalyzed by thymidine phosphorylase; used in metastatic breast and colon cancer.
44
azacitidine
pyrimidine analogue | o Used to treat myelodysplastic syndrome.
45
purine analogues
6 mercaptopurine and 6 thioguanine converted by HPRT S phase of cell cycle is most sensitive
46
asparaginase
catalyzes conversion of asparagine to aspartate --> inhibition of protein synthesis. o Toxicities: Reduction in concentration of secreted proteins (clotting factors, insulin, albumin, etc.), hypersensitivity reactions, hepatotoxicity.
47
kinase inhibitors
``` GIVES gefitinib imatinib mesylate vemurafenib erlotinib sorafenib ```
48
Imatinib mesylate
treats CML | ---blocks the ATP-binding site of the c-abl tyrosine kinase
49
vorinostat
• Histone deacetylase inhibitor; Used to treat cutaneous T cell lymphoma
50
all trans retinoic acid
(vitamin A) - First line therapy for promyelocytic leukemia
51
cetuximab
directed against EGF receptor
52
trastuzumab
cell-mediated cytotoxicity; |  .

53
bevacizumab
• Ab against VEGF; Designed to inhibit angiogenesis; | o risk of thromboembolic events;
54
rituximab
anti-CD20 monoclonal antibody | o Toxicity: can result in HBV reactivation.
55
ipilimumab? gemtuzumab ozogamicin? pembrolizumab?
TARGETs: - -CTLA-4 
--myeloid surface antigen CD33. - -PD-1 receptor (programmed cell death 1)
56
intrathecal methotrexate
CNS prophylactic into CSF - dihydrofolate reductase inhibitor that targets CNS since chemo doesn't cross into there but cancer can toxicity: meningitis